NCT04306432 Cognitive Function After Radiation Therapy for Primary Brain Tumours
| NCT ID | NCT04306432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Primary Brain Tumour |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2019-01-03 |
| Primary Completion | 2034-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2019-01-03 with a primary completion date of 2034-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.
Eligibility Criteria
Inclusion Criteria: * 18 years or older and Danish speaking. * Performance status WHO 0-2 * Capable of cooperating on testing * Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas Exclusion Criteria: * Glioblastoma * Performance status 3-4 (Karnofsky Performances of 60 or less)
Contact & Investigator
Lene Haldbo-Classen, M.D
PRINCIPAL INVESTIGATOR
Aarhus University Hospital
Frequently Asked Questions
Who can join the NCT04306432 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Primary Brain Tumour. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04306432 currently recruiting?
Yes, NCT04306432 is actively recruiting participants. Contact the research team at morthoey@rm.dk for enrollment information.
Where is the NCT04306432 trial being conducted?
This trial is being conducted at Copenhagen, Denmark, Aarhus, Denmark, Aarhus, Denmark, Aalborg, Denmark and 1 additional location.
Who is sponsoring the NCT04306432 clinical trial?
NCT04306432 is sponsored by University of Aarhus. The principal investigator is Lene Haldbo-Classen, M.D at Aarhus University Hospital. The trial plans to enroll 300 participants.